PAD inhibitors (Leiden University Medical Center/LURIS)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePAD inhibitors (Leiden University Medical Center/LURIS)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionPeptidyl Arginine Deiminase inhibitors
TargetsPeptidyl Arginine Deiminase
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLeiden University Medical Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLeiden University Medical CenterLeiden University
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A